Sg3 Management, LLC Idera Pharmaceuticals, Inc. Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.01 - $1.58 $35,047 - $54,826	-34,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.23 - $5.98 $42,681 - $207,506	34,700 New	34,700 $45,000
Q1 2019 May 14, 2019	SELL	$2.33 - $3.79 $17,922 - $29,152	-7,692 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.53 - $11.36 $42,536 - $87,381	7,692 New	7,692 $69,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.